Skip to main content

Specialty Pharmacy

  • Thrifty White Specialty Pharmacy gets CPPA accreditation
    WASHINGTON — The Center for Pharmacy Practice Accreditation has accredited Thrifty White Specialty Pharmacy, the organization announced Friday. Thrifty White, based in Fargo, N.D., offers its specialty patients full pharmacy support services and has expanded its capabilities to serve specialty patients in all 50 states, in addition to the specialty medication pickup it offers at 90 of its retail locations. 
     

  • Specialty Focused: DSN interviews Walgreens specialty pharmacy group VP

    The significant role that specialty pharmacies play in specialty care — from ensuring patients have access to their specific disease state treatment to delivering necessary training and other services around their medication — is something Walgreens Specialty Pharmacy knows well.

  • QuintilesIMS Institute report: Generics brought $227 billion in 2015 savings
    WASHINGTON —QuintilesIMS on Wednesday released its 2016 Generic Drug Savings and Access in the United States Report, which it compiled on behalf of the Generic Pharmaceutical Association (GPhA). 
     

  • Gilead honors Camber parent company Hetero Drugs
    PISCATAWAY, N.J. — Camber Pharmaceuticals announced Wednesday that its parent company, Hetero Drugs, has been recognized by Gilead Sciences for its work providing access to hepatitis C drugs for patients worldwide. Hetero markets sofosbuvir  as Sofovir and ledipasvir-sofosbuvir as Ledifos in India and will eventually reach some 91 countries. The two drugs are better known in the United States and as Sovaldi and Harvoni. 
     
    In India, an estimated 12 million to 18 million patients are infected with hepatitis C. 

  • Pfizer announces availability of Inflectra, its Remicade biosimilar
    NEW YORK — Pfizer on Tuesday announced that it will begin shipping its Inflectra (infliximab-dyyb), a biosimilar of Remicade (infliximab), to U.S. wholesalers starting at the end of November. 
     
    Inflectra will be the second biosimilar available in the United States, and the first biosimilar monoclonal antibody. Pfizer will introduce Inflectra at a 15% discount to the current wholesaler acquisition cost of Remicade.
     

  • Despite 2015 slowdown, specialty continues to grow share of health spend

    For the year ended May 2016, specialty medicines made up 36% of all drug spend, according to IMS Health data. And for the year-to-date as of May, specialty spending growth was at 23% — outpacing the 7.8% YTD spending growth that traditional medicines saw in the same time period.

  • Diplomat rolls out campaign celebrating American Pharmacists Month

  • Lupin, MonoSol Rx ink licensing agreement for pediatric products
    WARREN, New Jersey, BALTIMORE and MUMBAI — Lupin on Tuesday announced a new strategic licensing agreement with specialty pharmaceutical company MonoSol Rx. Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
     
X
This ad will auto-close in 10 seconds